IMMUNITYBIO, INC. Remaining Share Repurchase Authorization
IMMUNITYBIO, INC. (IBRX) had Remaining Share Repurchase Authorization of $18.30 million as of 2021-03-31, per its 10-Q filed 2021-05-14.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 · last filed 2021-05-14
- 2021-03-31: Stock Repurchase Program, Remaining Authorized Repurchase Amount $18.30M.
- 2020-12-31: Stock Repurchase Program, Remaining Authorized Repurchase Amount $18.30M.
- 2020-09-30: Stock Repurchase Program, Remaining Authorized Repurchase Amount $18.30M.
- 2020-06-30: Stock Repurchase Program, Remaining Authorized Repurchase Amount $18.30M.
| Period end | Stock Repurchase Program, Remaining Authorized Repurchase Amount |
|---|---|
| 2021-03-31 | $18.30M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $18.30M 8-K/A · filed 2021-04-22 |
| 2020-09-30 | $18.30M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $18.30M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $18.30M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $18.30M 10-K · filed 2020-03-25 |
| 2019-09-30 | $18.30M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $18.30M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $18.80M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $18.80M 10-K · filed 2019-03-13 |
| 2018-09-30 | $19.10M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $19.10M 10-Q · filed 2018-08-06 |
| 2018-03-31 | $19.10M 10-Q · filed 2018-05-07 |
| 2017-12-31 | $19.10M 10-K · filed 2018-03-12 |
| 2017-11-30 | $20.60M 10-K · filed 2018-03-12 |
| 2017-09-30 | $21.80M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $21.80M 10-K · filed 2018-03-12 |
| 2017-05-31 | $29.10M 10-K · filed 2018-03-12 |
| 2017-03-31 | $33.10M 10-K · filed 2018-03-12 |
| 2016-12-31 | $34.20M 10-K · filed 2017-03-15 |
| 2016-11-30 | $35.00M 10-K · filed 2017-03-15 |
| 2016-09-30 | $38.10M 10-K · filed 2017-03-15 |
| 2016-08-31 | $38.40M 10-K · filed 2017-03-15 |
| 2016-06-30 | $40.70M 10-K · filed 2017-03-15 |
| 2016-05-31 | $45.10M 10-K · filed 2017-03-15 |
| 2016-03-31 | $47.40M 10-Q · filed 2016-05-16 |
| 2016-02-29 | $47.50M 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |